(MNZO - EXXSUN CORP)

company profile

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.

Manzo Pharmaceuticals (MNZO) is trading at 0.000001

Open Price
0.000001
Previous close
0.000001
Previous close
0.000001
P/E Ratio
0
Sector
Health Care
Shares outstanding
1159522000
Primary exchange
OTC Markets
ISIN
US56510D1063